Skip to main content
Tinavi Medical Technologies Co.,Ltd. logo

Tinavi Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688277 ISIN · CNE100004256 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 760 across all filing types
Latest filing 2025-12-12 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688277

About Tinavi Medical Technologies Co.,Ltd.

https://www.tinavi.com/

Tinavi Medical Technologies Co.,Ltd. specializes in the design, development, and commercialization of orthopedic surgical robotic systems. Its primary offering, the TiRobot system, provides a multi-functional platform for spine and trauma surgeries, supporting procedures such as pedicle screw fixation and pelvic fracture reduction. The technology incorporates high-definition 3D imaging, precise mechanical arms, and advanced navigation software to facilitate minimally invasive operations with sub-millimeter accuracy. By integrating preoperative planning with real-time intraoperative guidance, the system aims to enhance surgical precision, reduce recovery times, and minimize radiation exposure for clinical teams. The company focuses on delivering intelligent robotic solutions to hospitals and specialized surgical centers to improve the consistency and safety of complex orthopedic interventions.

Recent filings

Filing Released Lang Actions
募集资金管理办法（2025年12月）
Capital/Financing Update Classification · 95% confidence The document is titled as a management method for the use and supervision of raised funds by the company, detailing rules and procedures for managing capital raised through securities issuance. It references regulatory frameworks related to securities issuance and capital management, such as the Shanghai Stock Exchange Sci-Tech Innovation Board listing rules and related supervisory guidelines. The content is a detailed internal policy document on the management and use of capital raised, including storage, usage, changes in use, supervision, and reporting requirements. It is not a financial report, earnings release, or announcement of voting results. It is a regulatory compliance and internal management document related to capital raising and fund management. This fits best under the category of Capital/Financing Update (CAP), as it concerns the management and use of capital raised by the company, rather than a report or announcement of results or governance changes.
2025-12-12 Chinese
第五届监事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of a resolution passed by the Supervisory Board (监事会) of Beijing Tianzhihang Medical Technology Co., Ltd. It details the decision to abolish the Supervisory Board and transfer its powers to the Board of Directors' Audit Committee. The document includes meeting details, voting results, and references to related regulatory compliance. It is not a full report but a formal announcement of a board/management change related to corporate governance structure. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report or financial statement, so it is not an Annual Report or Interim Report. It is not a regulatory filing or announcement of a report publication. Hence, the classification is MANG with high confidence.
2025-12-12 Chinese
对外投资管理办法（2025年12月）
Regulatory Filings Classification · 95% confidence The document is titled '北京天智航医疗科技股份有限公司 对外投资管理办法' which translates to 'Beijing Tianzhihang Medical Technology Co., Ltd. External Investment Management Measures'. It is a detailed internal policy document outlining the company's investment management procedures, approval authorities, decision-making processes, internal controls, and supervision mechanisms. It does not contain financial statements, earnings data, or regulatory disclosures. It is not an announcement or a report of financial results, nor is it related to governance changes or legal proceedings. It is a corporate internal management policy document related to investment management. Such documents do not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The closest fitting category from the provided list is Regulatory Filings (RNS) as a fallback for miscellaneous filings that do not neatly fit into other categories, since this is a regulatory internal management document but not a formal financial or governance report or announcement.
2025-12-12 Chinese
公司章程（2025年12月）
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association for Beijing Tinavi Medical Technologies Co., Ltd. It includes chapters on general provisions, business scope, shares, shareholders and shareholders' meetings, board of directors, senior management, financial accounting system, profit distribution, audit, notices and announcements, mergers, amendments to the articles, and other corporate governance matters. It references laws and regulations such as the Company Law, Securities Law, and Shanghai Stock Exchange rules. The content is about the internal rules, governance structure, shareholder rights, board responsibilities, and procedural rules for meetings and decision-making. There is no financial data, earnings information, or audit report results. It is not a report of financial performance or an announcement of voting results. It is a governance document detailing the company's internal rules and governance practices.
2025-12-12 Chinese
独立董事工作制度（2025年12月）
Governance Information Classification · 95% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It details the rules, responsibilities, nomination, election, and duties of independent directors within the company. The content is focused on governance practices, board structure, and the role of independent directors, referencing relevant laws and regulations. There are no financial statements, earnings data, or audit results. It is not a report of financial performance or an announcement of voting results. The document fits the description of a Governance Information report, which details the company's internal rules, board structure, and governance practices.
2025-12-12 Chinese
投资者关系管理办法（2025年12月）
Governance Information Classification · 95% confidence The document is titled as an "Investor Relations Management Measures" for Beijing Tianzhihang Medical Technology Co., Ltd. It outlines the principles, content, organization, and implementation of investor relations management, including communication with investors, information disclosure, and investor protection. It does not contain financial statements, earnings data, audit results, or any specific report content. Instead, it is a governance-related document detailing internal rules and procedures for managing investor relations and corporate governance practices. Therefore, it fits best under Governance Information (CGR). The document length (5712 characters) and detailed procedural content support this classification rather than a brief announcement or a financial report.
2025-12-12 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.